Sustainable Influenza Vaccine Production Capacity Stakeholder's Workshop
January 11-13, 2010
The U.S. Department of Health and Human Services (HHS) is committed to assisting in the creation of regionally-based, independent and sustainable vaccine production capacity in developing and emerging economy countries through capacity building and technology transfer. There is a need for a comprehensive framework and strategic plan that outlines and assesses the present state, future vision, and steps necessary to achieve the goals outlined in the World Health Organization's Global Pandemic Influenza Action Plan to Increase Vaccine Supply. This framework or 'roadmap' should be developed by a coalition of stakeholders.
Development of an effective vaccine is considered the cornerstone for controlling a global influenza pandemic. However, there are marked differences between countries regarding their capacities, priorities, and resources to establish seasonal and pandemic influenza vaccination policies and programs.
Building influenza vaccine production capacity in developing and emerging economy countries helps to address a number of critical issues including insufficient availability/access to pandemic vaccines and the need for sustainable approaches to self-sufficiency.
The success of this global initiatitve depends on collaborative effort and on the sustained and active engagement of all stakeholders.